Quoin Pharmaceuticals (QNRX) has received written notice from the Listing Qualifications Department of The Nasdaq Stock Market stating that the Company has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2). The notification from Nasdaq confirms that for the last 13 consecutive business days, the closing bid price of the Company’s ordinary shares was at or above $1.00 per share. Accordingly, Nasdaq considers the matter closed.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on QNRX:
- Quoin Pharmaceuticals Ltd – ADR trading resumes
- Quoin Pharmaceuticals Ltd – ADR trading halted, volatility trading pause
- Quoin Pharmaceuticals releases second episode of ‘Living with Netherton’ series
- Quoin Pharmaceuticals Ltd – ADR trading halted, news pending
- Upcoming Stock Splits This Week (April 7 to April 11) – Stay Invested
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue